Clinical Trial Update: A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures [Phase 3]

View source ↗

Summary

A long-term Phase 3 study assessing safety, tolerability, and efficacy of retigabine IR in Asian adults with partial onset seizures has completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Retigabine (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2019-04-22